Trxade Gross Margin from 2010 to 2024

MEDS Stock  USD 10.24  0.69  7.23%   
Check Trxade financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Trxade main balance sheet or income statement drivers, such as Interest Expense of 406 K, Selling General Administrative of 4.7 M or Other Operating Expenses of 8.2 M, as well as many exotic indicators such as Price To Sales Ratio of 4.88, Dividend Yield of 0.0 or Operating Cycle of 33.34. Trxade financial statements analysis is a perfect complement when working with Trxade Valuation or Volatility modules.
  
This module can also supplement various Trxade Technical models . Check out the analysis of Trxade Correlation against competitors.

About Trxade Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Trxade income statement, its balance sheet, and the statement of cash flows. Trxade investors use historical funamental indicators, such as Trxade's Gross Margin, to determine how well the company is positioned to perform in the future. Although Trxade investors may use each financial statement separately, they are all related. The changes in Trxade's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Trxade's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Trxade Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Trxade. Please read more on our technical analysis and fundamental analysis pages.
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. Trxade Health operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Trxade in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Trxade's short interest history, or implied volatility extrapolated from Trxade options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Trxade Group is a strong investment it is important to analyze Trxade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Trxade's future performance. For an informed investment choice regarding Trxade Stock, refer to the following important reports:
Check out the analysis of Trxade Correlation against competitors.
Note that the Trxade Group information on this page should be used as a complementary analysis to other Trxade's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Trxade Stock analysis

When running Trxade's price analysis, check to measure Trxade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trxade is operating at the current time. Most of Trxade's value examination focuses on studying past and present price action to predict the probability of Trxade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trxade's price. Additionally, you may evaluate how the addition of Trxade to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Trxade's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trxade. If investors know Trxade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trxade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.766
Earnings Share
(5.46)
Revenue Per Share
13.669
Quarterly Revenue Growth
0.001
Return On Assets
(0.14)
The market value of Trxade Group is measured differently than its book value, which is the value of Trxade that is recorded on the company's balance sheet. Investors also form their own opinion of Trxade's value that differs from its market value or its book value, called intrinsic value, which is Trxade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trxade's market value can be influenced by many factors that don't directly affect Trxade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trxade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trxade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trxade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.